A 'Desaturase hypothesis' for atherosclerosis: Janus-Faced enzymes in ω-6 and ω-3 polyunsaturated fatty acid metabolism

Journal of Nutrigenetics and Nutrigenomics

Volumn 2, Issue 3, 2009, Pages 129-139

  Martinelli, Nicola ^a   Consoli, Letizia ^a   Olivieri, Oliviero ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

3 fatty acids; 6 fatty acids; Coronary artery disease; Desaturase; FADS genes; Inflammation

Indexed keywords

ACYL COENZYME A DESATURASE; ARACHIDONIC ACID; ICOSANOID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID;

ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BIOAVAILABILITY; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; DIETARY INTAKE; ENZYME ACTIVITY; FATTY ACID METABOLISM; HAPLOTYPE; HUMAN; LIPID DIET; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SUPPLEMENTATION; VASCULITIS;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DIET; ENVIRONMENT; FATTY ACID DESATURASES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; LINOLEOYL-COA DESATURASE; MODELS, BIOLOGICAL;

EID: 70349258436     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000238177     Document Type: Short Survey

References (56)

1. Das UN: Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 2006; 1: 420-439.
2. Das UN: Essential fatty acids - a review. Curr Pharm Biotechnol 2006; 7: 467-482.
3. Brenner RR: Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 1982; 20: 41-48.
4. Breslow JL: - -3 fatty acids and cardiovascular disease. Am J Clin Nutr 2006; 83: 1577S- 1582S.
5. Erikkila AT, Lehto S, Pyorala K, Uusitupa MI: - -3 fatty acid and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 2003; 78: 65-71.
6. Riserus U: Fatty acids and insulin sensitivity. Curr Opin Clin Nutr Metab Care 2008; 11: 100-105.
7. De Caterina R, Zampolli A: From asthma to atherosclerosis-5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med 2004; 350: 4-7.
8. Ross R: Atherosclerosis an inflammatory disease. N Engl J Med 1999; 340: 115-126.
9. Libby P: Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
10. Kark JD, Kaufmann NA, Binka F, Goldberger N, Berry EM: Adipose tissue - -6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr 2003; 77: 796-802.
11. Baylin A, Campos H: Arachidonic acid in adipose tissue is associated with nonfatal acute myocardial infarction in the central valley of Costa Rica. J Nutr 2004; 134: 3095-3099.
12. James MJ, Gibson RA, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2007; 71: 343S-348S.
13. Davidson MH: Mechanisms for the hypotriglyceridemic effect of marine - -3 fatty acids. Am J Cardiol 2006; 98: 27-33.
14. Kumar KV, Das UN: Effect of cis-unsaturated fatty acids, prostaglandins and free radicals on angiotensin converting enzyme activity in vitro. Proc Soc Exp Biol Med 1997; 214: 374-379.
15. Das UN: Do unsaturated fatty acids function as endogenous anti-bacterial and antiviral molecules? Am J Clin Nutr 2006; 83: 390-391.
16. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG: A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005; 115: 2774-2783.
17. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N Jr, Ashe KH, Frautschy SA, Cole GM: Docosahexaenoic acid protects from dendritic pathology in an Alzheimer disease mouse model. Neuron 2004; 43: 633-645.
18. Cantwell MM, Flynn MA, Cronin D, O'Neill JP, Gibney MJ: Contribution of foods to trans unsaturated fatty acid intake in a group of Irish adults. J Hum Nutr Diet 2005; 18: 377-385.
19. Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PR: Dietary intakes and food sources of - -6 and - -3 polyunsaturated fatty acids. Lipids 2003; 38: 391-398.
20. Warenjo E, Risersus U, Vessby B: Fatty acid composition in serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005; 48: 1999-2005.
21. Harris WS, Assaad B, Poston WC: Tissue - - 6/ - -3 fatty acid ratio and risk for coronary artery disease. Am J Clin Cardiol 2006; 98: 19-26.
22. Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, Calder PC: Influence of dietary supplementation with long chain - -3 or - -6 polyunsaturated fatty acids on blood inflammatory cell populations and functions on plasma soluble adhesion molecules in healthy adults. Lipids 2001; 36: 1183-1193.
23. Obukowicz MG, Welsch DJ, Salsgiver WJ, Martin Berger CL, Chinn KS, Duffin KL, Raz A, Needleman P: Novel selective delta6 or delta5 fatty acid desaturase inhibitors as anti-inflammatory agent in mice. J Pharmacol Exp Ther 1998; 287: 157-166.
24. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M: Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid and atherosclerosis. N Engl J Med 2004; 350: 29-37.
25. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant S, Thorgeirsson S, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004; 36: 233-239.
26. GISSI dietary supplementation with - -3 polyunsaturated fatty acid and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-455.
27. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F, GISSIPrevenzione Investigators: Early protection against sudden death by - -3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)- Prevenzione. Circulation 2002; 105: 1897- 1903.
28. Leaf A, Kang JX, Xiao YF, Billman GE: Clinical prevention of sudden cardiac death by - -3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by - -3 fish oils. Circulation 2003; 107: 2646-2652.
29. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ: Blood pressure response to fish oil supplementation: Metaregression analysis of randomized trials. J Hypertens 2002; 20: 1493-1499.
30. Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association. Nutrition Committee: Fish consumption, fish oil, - -3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-2757.
31. McKenney JM, Sica D: Role of prescription - -3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy 2007; 27: 715-728.
32. Ohrvall M, Berglund L, Salminem I, Lithell H, Aro A, Vessby B: The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years' follow-up. Atherosclerosis 1996; 127: 65-71.
33. Harris WS, Poston WC, Haddock CK: Tissue - -3 and - -6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007; 193: 1-10.
34. Laaksonen DE, Nyyssönen K, Niskanen L, Rissanen TH, Salonen JT: Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 2005; 165: 193-199.
35. Harris WS, Mozaffarian D, Rimm E, Kris- Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F: - -6 fatty acids and risk for cardiovascular disease: A science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119: 902-907.
36. Bernal-Mizrachi C, Gates AC, Weng S, Imamura T, Knutsen RH, DeSantis P, Coleman T, Townsend RR, Muglia LJ, Semenkovich CF: Cardiovascular respiratory uncoupling increases blood pressure and atherosclerosis. Nature 2005; 435: 502-506.
37. Cho HP, Nakamura M, Clarke SD: Cloning, expression and fatty acid regulation of the human delta-5 desaturase. J Biol Chem 1999; 274: 37335-37339.
38. Cho HP, Nakamura M, Clarke SD: Cloning, expression and nutritional regulation of the mammalian delta-6 desaturase. J Biol Chem 1999; 274: 471-477. (Pubitemid 29035085)
39. Das UN: A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007; 76: 251-268.
40. Nakamura MT, Nara TY: Structure, function, and dietary regulation of delta6, delta5 and delta9 desaturases. Annu Rev Nutr 2004; 24: 345-376.
41. Malerba G, Schaeffer L, Xumerle L, Klopp N, Trabetti E, Biscuola M, Cavallari U, Galavotti R, Martinelli N, Guarini P, Girelli D, Olivieri O, Corrocher R, Heinrich J, Pignatti PF, Illig T: SNIPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008; 43: 289-299.
42. Schaeffer L, Gohlke H, Müller M, Heid IM, Palmer LJ, Kompauer I, Demmelmair H, Illig T, Koletzko B, Heinrich J: Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006; 15: 1745-1756.
43. Pacher P, Batkai S, Kunos G: The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006; 58: 389-462.
44. Narce M, Asdrubal P, Delachambre MC, Varicel E, Lagarde M, Poisson JP: Age-related changes in linoleic acid bioconversion by isolated hepaytocytes from spontaneously hypertensive and normotensive rats. Mol Cell Biochem 1994; 141: 9-13.
45. Sundstrom J, Lind L, Vessby B, Andren B, Aro A, Lithell H: Dyslipidemia and an unfavourable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 2001; 103: 836-841.
46. Vessby B: Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003; 14: 15-19.
47. Warensjo E, Ohrvall M, Vessby B: Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis 2006; 16: 128-136.
48. Russo C, Olivieri O, Girelli D, Guarini P, Pasqualini R, Azzini M, Corrocher R: Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension. Hypertension 1997; 29: 1058-1063.
49. Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E, Sandri M, Friso S, Pizzolo F, Schaeffer L, Heinrich J, Pignatti PF, Corrocher R, Olivieri O: FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008; 88: 941-949.
50. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, Faux JA, Ryan GF, le Söuef PN, Lathrop GM, Musk AW, Cookson WO: A genome-wide search for quantitative trait loci underlying asthma. Nature 1996; 383: 247-250.
51. Loetzer K, Funk CD, Habenicht AJ: The 5- lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim Biophys Acta 2005; 1736: 30-37.
52. Baylin A, Ruiz-Navarez E, Kraft P, Campos H: Alpha linolenic acid delta6-desaturase gene polymorphism and the risk of nonfatal myocardial infarction. Am J Clin Nutr 2007; 85: 554-560.
53. Lusis AJ, Pajukanta P: A treasure trove for lipoprotein biology. Nat Genet 2008; 40: 129-130.
54. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, Zelenika D, Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Bergman RN, Sundvall J, Laakso M, Ferrucci L, Scheet P, Sanna S, Uda M, Yang Q, Lunetta KL, Dupuis J, de Bakker PI, O'Donnell CJ, Chambers JC, Kooner JS, Hercberg S, Meneton P, Lakatta EG, Scuteri A, Schlessinger D, Tuomilehto J, Collins FS, Groop L, Altshuler D, Collins R, Lathrop GM, Melander O, Salomaa V, Peltonen L, Orho-Melander M, Ordovas JM, Boehnke M, Abecasis GR, Mohlke KL, Cupples LA: Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2008; 41: 56-65.
55. Tanaka T, Shen J, Abecasis GR, Kisialiou A, Ordovas JM, Guralnik JM, Singleton A, Bandinelli S, Cherubini A, Arnett D, Tsai MY, Ferrucci L: Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 2009; 5: E1000338
56. Simopoulos AP: Evolutionary aspects of diet, the - -6/ - -3 ratio and genetic variation: Nutritional implication for chronic diseases. Biomed Pharmacother 2006; 60: 502-507.